Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?

Autor: Laloux, C., Gouel, F., Lachaud, C., Timmerman, K., Do Van, B., Jonneaux, A., Petrault, M., Garcon, G., Rouaix, N., Moreau, C., Bordet, R., Duce, J.A., Devedjian, J.C., Devos, D.

Publikováno v: In Neurobiology of Disease July 2017 103:24-31

Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope.

Autor: Zhang, Xiaojie¹ (AUTHOR), Tang, Bufu^1,2 (AUTHOR), Luo, Jinhua¹ (AUTHOR), Yang, Yang^1,3,4 (AUTHOR), Weng, Qiaoyou^1,3,4 (AUTHOR), Fang, Shiji^1,3,4 (AUTHOR), Zhao, Zhongwei^1,3,4 (AUTHOR), Tu, Jianfei^1,3,4 (AUTHOR) jianfei1133@163.com, Chen, Minjiang^1,3,4 (AUTHOR) minjiangchen@wmu.edu.cn, Ji, Jiansong^1,3,4 (AUTHOR) jjstcty@wmu.edu.cn

Publikováno v: Molecular Cancer. 11/15/2024, Vol. 23 Issue 1, p1-30. 30p.

Amphetamine-like Deferiprone and Clioquinol Derivatives as Iron Chelating Agents.

Autor: El Safadi, Mahmoud^1,2 (AUTHOR) mahmoudelsafadi@uaeu.ac.ae, Wilson, Katie A.^3,4 (AUTHOR) k.wilson@mun.ca, Strudwicke, Indigo J.³ (AUTHOR) indigo.strudwicke@anu.edu.au, O'Mara, Megan L.^3,5 (AUTHOR) m.omara@uq.edu.au, Bhadbhade, Mohan⁶ (AUTHOR) m.bhadbhade@unsw.edu.au, Rawling, Tristan¹ (AUTHOR) tristan.rawling@uts.edu.au, McDonagh, Andrew M.¹ (AUTHOR) andrew.mcdonagh@uts.edu.au

Publikováno v: Molecules. Sep2024, Vol. 29 Issue 17, p4213. 10p.

Mitochondria-mediated Ferroptosis in Diseases Therapy: From Molecular Mechanisms to Implications.

Autor: Fuhai Feng¹, Shasha He², Xiaoling Li³, Jiake He¹, Lianxiang Luo^4,5 luolianxiang321@gdmu.edu.cn

Publikováno v: Aging & Disease. Apr2024, Vol. 15 Issue 2, p714-738. 25p.

The protective effect of human platelet lysate in models of neurodegenerative disease: involvement of the Akt and MEK pathways.

Autor: Gouel F; Department of Medical Pharmacology/INSERM U1171, Lille Faculty of Medicine, Lille University Medical Center and Lille Nord de France University, Lille, France., Do Van B; Department of Medical Pharmacology/INSERM U1171, Lille Faculty of Medicine, Lille University Medical Center and Lille Nord de France University, Lille, France., Chou ML; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan., Jonneaux A; Department of Medical Pharmacology/INSERM U1171, Lille Faculty of Medicine, Lille University Medical Center and Lille Nord de France University, Lille, France., Moreau C; Department of Movement Disorders and Neurology, Lille University Medical Center and Lille Nord de France University, Lille, France., Bordet R; Department of Medical Pharmacology/INSERM U1171, Lille Faculty of Medicine, Lille University Medical Center and Lille Nord de France University, Lille, France., Burnouf T; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Devedjian JC; Department of Medical Pharmacology/INSERM U1171, Lille Faculty of Medicine, Lille University Medical Center and Lille Nord de France University, Lille, France.; Université du Littoral Cote d'Opale, Calais, France., Devos D; Department of Medical Pharmacology/INSERM U1171, Lille Faculty of Medicine, Lille University Medical Center and Lille Nord de France University, Lille, France.; Department of Movement Disorders and Neurology, Lille University Medical Center and Lille Nord de France University, Lille, France.

Publikováno v: Journal of tissue engineering and regenerative medicine [J Tissue Eng Regen Med] 2017 Nov; Vol. 11 (11), pp. 3236-3240. Date of Electronic Publication: 2016 Dec 12.